BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18481983)

  • 41. Regulation of SQSTM1/p62 via UBA domain ubiquitination and its role in disease.
    Lee Y; Weihl CC
    Autophagy; 2017 Sep; 13(9):1615-1616. PubMed ID: 28812433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
    Laurin N; Brown JP; Morissette J; Raymond V
    Am J Hum Genet; 2002 Jun; 70(6):1582-8. PubMed ID: 11992264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of a novel ubiquitin binding site of STAM1 VHS domain by NMR spectroscopy.
    Hong YH; Ahn HC; Lim J; Kim HM; Ji HY; Lee S; Kim JH; Park EY; Song HK; Lee BJ
    FEBS Lett; 2009 Jan; 583(2):287-92. PubMed ID: 19111546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases.
    Zatloukal K; Stumptner C; Fuchsbichler A; Heid H; Schnoelzer M; Kenner L; Kleinert R; Prinz M; Aguzzi A; Denk H
    Am J Pathol; 2002 Jan; 160(1):255-63. PubMed ID: 11786419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bcl-2 Decreases the Affinity of SQSTM1/p62 to Poly-Ubiquitin Chains and Suppresses the Aggregation of Misfolded Protein in Neurodegenerative Disease.
    Zhou L; Wang H; Ren H; Hu Q; Ying Z; Wang G
    Mol Neurobiol; 2015 Dec; 52(3):1180-1189. PubMed ID: 25311206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of p62/SQSTM1 antibodies for neuropathological diagnosis.
    Kuusisto E; Kauppinen T; Alafuzoff I
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):169-80. PubMed ID: 17961133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro production of Mallory bodies and intracellular hyaline bodies: the central role of sequestosome 1/p62.
    Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Hepatology; 2007 Sep; 46(3):851-60. PubMed ID: 17685470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of ubiquitin in NF-kappaB regulatory pathways.
    Skaug B; Jiang X; Chen ZJ
    Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RANK/RANKL: regulators of immune responses and bone physiology.
    Leibbrandt A; Penninger JM
    Ann N Y Acad Sci; 2008 Nov; 1143():123-50. PubMed ID: 19076348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ref(2)P, the Drosophila melanogaster homologue of mammalian p62, is required for the formation of protein aggregates in adult brain.
    Nezis IP; Simonsen A; Sagona AP; Finley K; Gaumer S; Contamine D; Rusten TE; Stenmark H; Brech A
    J Cell Biol; 2008 Mar; 180(6):1065-71. PubMed ID: 18347073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atypical binding of the Swa2p UBA domain to ubiquitin.
    Matta-Camacho E; Kozlov G; Trempe JF; Gehring K
    J Mol Biol; 2009 Feb; 386(2):569-77. PubMed ID: 18948116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ubiquitin-mediated signalling and Paget's disease of bone.
    Layfield R; Shaw B
    BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S5. PubMed ID: 18047742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes.
    Karin M; Gallagher E
    Immunol Rev; 2009 Mar; 228(1):225-40. PubMed ID: 19290931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular modelling and dynamic simulations of sequestosome 1 (SQSTM1) missense mutations linked to Paget disease of bone.
    Shaik NA; Nasser KK; Alruwaili MM; Alallasi SR; Elango R; Banaganapalli B
    J Biomol Struct Dyn; 2021 May; 39(8):2873-2884. PubMed ID: 32329415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure and functional properties of the ubiquitin binding protein p62.
    Geetha T; Wooten MW
    FEBS Lett; 2002 Feb; 512(1-3):19-24. PubMed ID: 11852044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequestosome 1/p62: across diseases.
    Geetha T; Vishwaprakash N; Sycheva M; Babu JR
    Biomarkers; 2012 Mar; 17(2):99-103. PubMed ID: 22296116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders.
    Ralston SH
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):101-11. PubMed ID: 18328984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ubiquitin-proteasome system and neurodegenerative disorders.
    Layfield R; Lowe J; Bedford L
    Essays Biochem; 2005; 41():157-71. PubMed ID: 16250904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PB1 and UBA domains of p62 are essential for aggresome-like induced structure formation.
    Cabe M; Rademacher DJ; Karlsson AB; Cherukuri S; Bakowska JC
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2306-2311. PubMed ID: 29966650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sequestosome 1/p62--more than just a scaffold.
    Seibenhener ML; Geetha T; Wooten MW
    FEBS Lett; 2007 Jan; 581(2):175-9. PubMed ID: 17188686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.